Dermatophytic Onychomycosis Market Report

Global and Region Dermatophytic Onychomycosis Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：161
  • REPORT CODE：GMM994030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.

    The report details the trend, potential and market size of Dermatophytic Onychomycosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Dermatophytic Onychomycosismarket, defines the market attractiveness level of Dermatophytic Onychomycosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Dermatophytic Onychomycosis industry, describes the types of Dermatophytic Onychomycosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dermatophytic Onychomycosis market and the development prospects and opportunities of Dermatophytic Onychomycosis industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dermatophytic Onychomycosis market in Chapter 13.

    By Player:

    • NovaBiotics

    • Promius Pharma

    • Pfizer

    • Seren Pharmaceuticals

    • Nuvo Research

    • Hexima

    • Meiji Seika Pharma

    • Abeona Therapeutics

    • Anacor Pharmaceuticals

    • Topica Pharmaceuticals

    • Taro Pharmaceutical

    • Mayne Pharma

    • Novartis

    • Sanofi

    • Hisamitsu Pharmaceutical

    • NanoBio

    • Merz Pharma

    • Viamet Pharmaceuticals

    • Allergan

    • Galderma

    • Elorac

    • Moberg Pharma

    • Polichem

    • MediQuest Therapeutics

    • Valeant Pharmaceuticals

    • Janssen Biotech

    • GlaxoSmithKline

    By Type:

    • Oral

    • Topical

    By End-User:

    • Hospitals

    • Clinics and laboratories

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Dermatophytic Onychomycosis Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Dermatophytic Onychomycosis Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Dermatophytic Onychomycosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Dermatophytic Onychomycosis Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Dermatophytic Onychomycosis Market Analysis and Outlook to 2022

    • 7.1 Global Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.2 United States Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.3 Europe Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.4 China Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.5 Japan Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.6 India Dermatophytic Onychomycosis Consumption (2017-2022)

    • 7.7 South Korea Dermatophytic Onychomycosis Consumption (2017-2022)

    8 Region and Country-wise Dermatophytic Onychomycosis Market Analysis and Outlook to 2028

    • 8.1 Global Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.2 United States Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.3 Europe Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.4 China Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.5 Japan Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.6 India Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    • 8.7 South Korea Dermatophytic Onychomycosis Consumption Forecast (2022-2028)

    9 Global Dermatophytic Onychomycosis Market Outlook by Types and Applications to 2022

    • 9.1 Global Dermatophytic Onychomycosis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Topical Consumption and Growth Rate (2017-2022)

    • 9.2 Global Dermatophytic Onychomycosis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics and laboratories Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Dermatophytic Onychomycosis Market Outlook by Types and Applications to 2028

    • 10.1 Global Dermatophytic Onychomycosis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Topical Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Dermatophytic Onychomycosis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics and laboratories Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Dermatophytic Onychomycosis Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Dermatophytic Onychomycosis Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Dermatophytic Onychomycosis Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Dermatophytic Onychomycosis Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Dermatophytic Onychomycosis Market Competitive Analysis

    • 14.1 NovaBiotics

      • 14.1.1 NovaBiotics Company Details

      • 14.1.2 NovaBiotics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 NovaBiotics Dermatophytic Onychomycosis Product and Service

    • 14.2 Promius Pharma

      • 14.2.1 Promius Pharma Company Details

      • 14.2.2 Promius Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Promius Pharma Dermatophytic Onychomycosis Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Dermatophytic Onychomycosis Product and Service

    • 14.4 Seren Pharmaceuticals

      • 14.4.1 Seren Pharmaceuticals Company Details

      • 14.4.2 Seren Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Seren Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • 14.5 Nuvo Research

      • 14.5.1 Nuvo Research Company Details

      • 14.5.2 Nuvo Research Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Nuvo Research Dermatophytic Onychomycosis Product and Service

    • 14.6 Hexima

      • 14.6.1 Hexima Company Details

      • 14.6.2 Hexima Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Hexima Dermatophytic Onychomycosis Product and Service

    • 14.7 Meiji Seika Pharma

      • 14.7.1 Meiji Seika Pharma Company Details

      • 14.7.2 Meiji Seika Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Meiji Seika Pharma Dermatophytic Onychomycosis Product and Service

    • 14.8 Abeona Therapeutics

      • 14.8.1 Abeona Therapeutics Company Details

      • 14.8.2 Abeona Therapeutics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abeona Therapeutics Dermatophytic Onychomycosis Product and Service

    • 14.9 Anacor Pharmaceuticals

      • 14.9.1 Anacor Pharmaceuticals Company Details

      • 14.9.2 Anacor Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • 14.10 Topica Pharmaceuticals

      • 14.10.1 Topica Pharmaceuticals Company Details

      • 14.10.2 Topica Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Topica Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • 14.11 Taro Pharmaceutical

      • 14.11.1 Taro Pharmaceutical Company Details

      • 14.11.2 Taro Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Taro Pharmaceutical Dermatophytic Onychomycosis Product and Service

    • 14.12 Mayne Pharma

      • 14.12.1 Mayne Pharma Company Details

      • 14.12.2 Mayne Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Mayne Pharma Dermatophytic Onychomycosis Product and Service

    • 14.13 Novartis

      • 14.13.1 Novartis Company Details

      • 14.13.2 Novartis Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novartis Dermatophytic Onychomycosis Product and Service

    • 14.14 Sanofi

      • 14.14.1 Sanofi Company Details

      • 14.14.2 Sanofi Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Sanofi Dermatophytic Onychomycosis Product and Service

    • 14.15 Hisamitsu Pharmaceutical

      • 14.15.1 Hisamitsu Pharmaceutical Company Details

      • 14.15.2 Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Product and Service

    • 14.16 NanoBio

      • 14.16.1 NanoBio Company Details

      • 14.16.2 NanoBio Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 NanoBio Dermatophytic Onychomycosis Product and Service

    • 14.17 Merz Pharma

      • 14.17.1 Merz Pharma Company Details

      • 14.17.2 Merz Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Merz Pharma Dermatophytic Onychomycosis Product and Service

    • 14.18 Viamet Pharmaceuticals

      • 14.18.1 Viamet Pharmaceuticals Company Details

      • 14.18.2 Viamet Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Viamet Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • 14.19 Allergan

      • 14.19.1 Allergan Company Details

      • 14.19.2 Allergan Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Allergan Dermatophytic Onychomycosis Product and Service

    • 14.20 Galderma

      • 14.20.1 Galderma Company Details

      • 14.20.2 Galderma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Galderma Dermatophytic Onychomycosis Product and Service

    • 14.21 Elorac

      • 14.21.1 Elorac Company Details

      • 14.21.2 Elorac Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Elorac Dermatophytic Onychomycosis Product and Service

    • 14.22 Moberg Pharma

      • 14.22.1 Moberg Pharma Company Details

      • 14.22.2 Moberg Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Moberg Pharma Dermatophytic Onychomycosis Product and Service

    • 14.23 Polichem

      • 14.23.1 Polichem Company Details

      • 14.23.2 Polichem Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Polichem Dermatophytic Onychomycosis Product and Service

    • 14.24 MediQuest Therapeutics

      • 14.24.1 MediQuest Therapeutics Company Details

      • 14.24.2 MediQuest Therapeutics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 MediQuest Therapeutics Dermatophytic Onychomycosis Product and Service

    • 14.25 Valeant Pharmaceuticals

      • 14.25.1 Valeant Pharmaceuticals Company Details

      • 14.25.2 Valeant Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Valeant Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • 14.26 Janssen Biotech

      • 14.26.1 Janssen Biotech Company Details

      • 14.26.2 Janssen Biotech Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Janssen Biotech Dermatophytic Onychomycosis Product and Service

    • 14.27 GlaxoSmithKline

      • 14.27.1 GlaxoSmithKline Company Details

      • 14.27.2 GlaxoSmithKline Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 GlaxoSmithKline Dermatophytic Onychomycosis Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Dermatophytic Onychomycosis

    • Figure Dermatophytic Onychomycosis Picture

    • Table Global Dermatophytic Onychomycosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dermatophytic Onychomycosis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dermatophytic Onychomycosis Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Dermatophytic Onychomycosis Consumption by Country (2017-2022)

    • Figure United States Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Table Europe Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure China Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure Japan Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure India Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Dermatophytic Onychomycosis Consumption and Growth Rate (2017-2022)

    • Figure Global Dermatophytic Onychomycosis Consumption Forecast by Country (2022-2028)

    • Figure United States Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Dermatophytic Onychomycosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Topical Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics and laboratories Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics and laboratories Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Dermatophytic Onychomycosis Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Dermatophytic Onychomycosis Export by Region (Top 5 Countries) (2017-2028)

    • Table NovaBiotics (Foundation Year, Company Profile and etc.)

    • Table NovaBiotics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table NovaBiotics Dermatophytic Onychomycosis Product and Service

    • Table Promius Pharma (Foundation Year, Company Profile and etc.)

    • Table Promius Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promius Pharma Dermatophytic Onychomycosis Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Dermatophytic Onychomycosis Product and Service

    • Table Seren Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Seren Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seren Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • Table Nuvo Research (Foundation Year, Company Profile and etc.)

    • Table Nuvo Research Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nuvo Research Dermatophytic Onychomycosis Product and Service

    • Table Hexima (Foundation Year, Company Profile and etc.)

    • Table Hexima Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hexima Dermatophytic Onychomycosis Product and Service

    • Table Meiji Seika Pharma (Foundation Year, Company Profile and etc.)

    • Table Meiji Seika Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meiji Seika Pharma Dermatophytic Onychomycosis Product and Service

    • Table Abeona Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Abeona Therapeutics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abeona Therapeutics Dermatophytic Onychomycosis Product and Service

    • Table Anacor Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Anacor Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anacor Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • Table Topica Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Topica Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Topica Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • Table Taro Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Taro Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taro Pharmaceutical Dermatophytic Onychomycosis Product and Service

    • Table Mayne Pharma (Foundation Year, Company Profile and etc.)

    • Table Mayne Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mayne Pharma Dermatophytic Onychomycosis Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Dermatophytic Onychomycosis Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Dermatophytic Onychomycosis Product and Service

    • Table Hisamitsu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Product and Service

    • Table NanoBio (Foundation Year, Company Profile and etc.)

    • Table NanoBio Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoBio Dermatophytic Onychomycosis Product and Service

    • Table Merz Pharma (Foundation Year, Company Profile and etc.)

    • Table Merz Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merz Pharma Dermatophytic Onychomycosis Product and Service

    • Table Viamet Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Viamet Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Viamet Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Dermatophytic Onychomycosis Product and Service

    • Table Galderma (Foundation Year, Company Profile and etc.)

    • Table Galderma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galderma Dermatophytic Onychomycosis Product and Service

    • Table Elorac (Foundation Year, Company Profile and etc.)

    • Table Elorac Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elorac Dermatophytic Onychomycosis Product and Service

    • Table Moberg Pharma (Foundation Year, Company Profile and etc.)

    • Table Moberg Pharma Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moberg Pharma Dermatophytic Onychomycosis Product and Service

    • Table Polichem (Foundation Year, Company Profile and etc.)

    • Table Polichem Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Polichem Dermatophytic Onychomycosis Product and Service

    • Table MediQuest Therapeutics (Foundation Year, Company Profile and etc.)

    • Table MediQuest Therapeutics Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table MediQuest Therapeutics Dermatophytic Onychomycosis Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Dermatophytic Onychomycosis Product and Service

    • Table Janssen Biotech (Foundation Year, Company Profile and etc.)

    • Table Janssen Biotech Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Biotech Dermatophytic Onychomycosis Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Dermatophytic Onychomycosis Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Dermatophytic Onychomycosis Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US